ChEMBL ID: CHEMBL4594385
Mechanism of action: IL-33 receptor (ST2) inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to ASTEGOLIMAB